Phenotypes and experiences of reproductive affective disorders among women in the Netherlands
- Conditions
- PMSPremenstrual disorders1002794610018057
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 250
For the observational prospective cohort study women must meet the following
criteria:
All participants must give signed informed consent.
All participants must be of fertile age (16 years of age or older, with a
maximum of 60 years).
Participants must experience self-reported PMS or PMDD related symptoms.
Participants must have a detectable cycle, which may either be a natural
menstrual cycle or induced by hormonal contraceptives, of no longer than 40
days.
A potential subject who meets any of the following criteria will be excluded
from the observational prospective cohort study:
Current pregnancy, or actively trying to conceive
Insufficient proficiency in Dutch
A potential subject who meets any of the following criteria will be excluded
from the validation study:
Current pregnancy, or actively trying to conceive
Insufficient proficiency in Dutch
Any current DSM-5 Axis 1 clinical disorder (other than PMDD) according to the
SCID interview
Current use of psychopharmaceutical medication
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study parameter is PMM/PMDD symptomatology as assessed using the<br /><br>C-PASS questionnaire.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary parameters are clinical diagnosis (SCID in validation study only),<br /><br>PMDD symptoms, co-morbid somatic and mental symptoms (GRSR, EPDS, PANAS, PQ-16,<br /><br>BSI-18, ADHD-screener, ASSIST-Lite), personality (DAPP-sf, HSP), quality of<br /><br>life (Q-LES-Q-SF), days of sick leave, disease course, medication use, service<br /><br>use, wellbeing, social functioning, psychiatric symptoms and history. </p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.